Sign in
PTHS Stock Price, Chart, Stats & News
Pelthos Therapeutics Inc.
Save
Pelthos Therapeutics Inc. (PTHS) does not currently pay a dividend.
77.12M
Market cap
–
Current P/E
–
Forward P/E
PTHS chart
About
Pelthos Therapeutics Inc. operates as a biopharmaceutical enterprise dedicated to developing and commercializing innovative medical treatments that address significant, unmet patient needs. Its primary offerings include ZELSUVMI, a medication specifically indicated for the treatment of molluscum contagiosum in individuals aged one year and older. Furthermore, the company leverages NITRICIL, an exclusive technological platform grounded in nitric oxide research.
Similar securities
Based on sector and market capitalization
Report issue